Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multicenter, Double-blind, Placebo-controlled Efficacy and Safety Study of 8 mg PEG-uricase in Two Dose Regimens in Hyperuricemic Subjects With Symptomatic Gout

NCT00325195 is registered in ClinicalTrials.gov with Savient Pharmaceuticals as lead sponsor.

NCT NCT00325195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00325195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multicenter, Double-blind, Placebo-controlled Efficacy and Safety Study of 8 mg PEG-uricase in Two Dose Regimens in Hyperuricemic Subjects With Symptomatic Gout
Lead sponsor
Savient Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
December 31, 2007
Enrollment
225 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

gout